1. Home
  2. PVLA vs RNGR Comparison

PVLA vs RNGR Comparison

Compare PVLA & RNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • RNGR
  • Stock Information
  • Founded
  • PVLA 2015
  • RNGR 2017
  • Country
  • PVLA United States
  • RNGR United States
  • Employees
  • PVLA N/A
  • RNGR N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • RNGR Oilfield Services/Equipment
  • Sector
  • PVLA Health Care
  • RNGR Energy
  • Exchange
  • PVLA Nasdaq
  • RNGR Nasdaq
  • Market Cap
  • PVLA 280.4M
  • RNGR 279.8M
  • IPO Year
  • PVLA N/A
  • RNGR 2017
  • Fundamental
  • Price
  • PVLA $22.77
  • RNGR $11.31
  • Analyst Decision
  • PVLA Strong Buy
  • RNGR Hold
  • Analyst Count
  • PVLA 7
  • RNGR 2
  • Target Price
  • PVLA $44.43
  • RNGR $12.50
  • AVG Volume (30 Days)
  • PVLA 82.1K
  • RNGR 115.8K
  • Earning Date
  • PVLA 05-15-2025
  • RNGR 04-29-2025
  • Dividend Yield
  • PVLA N/A
  • RNGR 2.13%
  • EPS Growth
  • PVLA N/A
  • RNGR 27.70
  • EPS
  • PVLA N/A
  • RNGR 0.87
  • Revenue
  • PVLA N/A
  • RNGR $569,400,000.00
  • Revenue This Year
  • PVLA N/A
  • RNGR $11.70
  • Revenue Next Year
  • PVLA N/A
  • RNGR N/A
  • P/E Ratio
  • PVLA N/A
  • RNGR $12.80
  • Revenue Growth
  • PVLA N/A
  • RNGR N/A
  • 52 Week Low
  • PVLA $6.20
  • RNGR $9.27
  • 52 Week High
  • PVLA $29.27
  • RNGR $18.45
  • Technical
  • Relative Strength Index (RSI)
  • PVLA N/A
  • RNGR 39.48
  • Support Level
  • PVLA N/A
  • RNGR $11.05
  • Resistance Level
  • PVLA N/A
  • RNGR $12.39
  • Average True Range (ATR)
  • PVLA 0.00
  • RNGR 0.61
  • MACD
  • PVLA 0.00
  • RNGR 0.00
  • Stochastic Oscillator
  • PVLA 0.00
  • RNGR 32.98

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About RNGR Ranger Energy Services Inc.

Ranger Energy Services Inc is a provider of onshore high-specification (high-spec) well service rigs, wireline services, and additional processing solutions and ancillary services in the United States. It offers a range of well-site services to U.S. exploration and production (E&P) companies that are fundamental to establishing and enhancing the flow of oil and natural gas throughout the productive life of a well. The segments of the group are High Specification Rigs, Wireline Services and Processing Solutions, and Ancillary Services, of which key revenue is derived from the High Specification Rigs segment.

Share on Social Networks: